2018
DOI: 10.1016/j.atherosclerosissup.2018.04.416
|View full text |Cite
|
Sign up to set email alerts
|

Familial Chylomicronemia Syndrome (FCS): Medical Nutrition Therapy Guidelines for Patients and Healthcare Providers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…There are no FDA approved treatments for FCS and patients are managed with a low-fat diet. Due to the rarity of FCS there are few case series describing phenotypic variability in this disorder [10].…”
Section: Discussionmentioning
confidence: 99%
“…There are no FDA approved treatments for FCS and patients are managed with a low-fat diet. Due to the rarity of FCS there are few case series describing phenotypic variability in this disorder [10].…”
Section: Discussionmentioning
confidence: 99%